Managing Psoriatic Arthritis: Updated 2018 Recommendations From ACR/NPF
The American College of Rheumatology and the National Psoriasis Foundation have released 2018 joint recommendations for the treatment of psoriatic arthritis.
The American College of Rheumatology and the National Psoriasis Foundation have released 2018 joint recommendations for the treatment of psoriatic arthritis.
Data show that the elderly are underrepresented in randomized clinical trials for rheumatoid arthritis and osteoarthritis.
Childhood maltreatment was associated with adulthood arthritis, particularly among those who experienced severe or frequent abuse.
A recent systematic review found that nurse-led care is effective, acceptable, and safe in patients with rheumatoid arthritis.
Most mobile apps directed toward individuals with rheumatoid arthritis do not provide a comprehensive experience.
The FDA has released a Biosimilar Action Plan to promote competition and affordability across the market for biologic and biosimilar products.
Investigators evaluated trends in the length and readability of informed consent forms for industry-sponsored clinical trials in rheumatology.
Five principles and 8 consensus recommendations for the use of biosimilars were made following a systematic literature review.
The CDC observed an increase in the age-adjusted prevalence of reporting healthcare provider counseling for exercise from 2002 to 2014.
Patients with rheumatoid arthritis, Sjögren’s syndrome, systemic lupus erythematosus, psoriatic arthritis, and osteoarthritis had a higher risk of dementia than those without rheumatic diseases.